SEC FILINGS 8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: November 21, 2018 - 11:15 am10-Q - Quarterly report [Sections 13 or 15(d)]Source: Adhera Therapeutics, Inc. (0000737207) | Published: November 19, 2018 - 9:39 pmNT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBSource: Adhera Therapeutics, Inc. (0000737207) | Published: November 15, 2018 - 3:39 pm8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: November 14, 2018 - 9:30 pm8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: October 25, 2018 - 8:30 pm8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: October 9, 2018 - 12:30 pm8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: October 3, 2018 - 12:30 pm8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: September 24, 2018 - 8:30 pmDEF 14A - Other definitive proxy statementsSource: Adhera Therapeutics, Inc. (0000737207) | Published: September 18, 2018 - 8:00 pmPRE 14A - Other preliminary proxy statementsSource: Adhera Therapeutics, Inc. (0000737207) | Published: September 6, 2018 - 9:01 pm10-Q - Quarterly report [Sections 13 or 15(d)]Source: Adhera Therapeutics, Inc. (0000737207) | Published: August 10, 2018 - 9:22 pmD - Notice of Exempt Offering of SecuritiesSource: Adhera Therapeutics, Inc. (0000737207) | Published: July 25, 2018 - 10:15 am8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: July 16, 2018 - 1:02 pm8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: June 29, 2018 - 1:30 pm8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: June 20, 2018 - 3:40 pm8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: May 18, 2018 - 9:10 pm10-Q - Quarterly report [Sections 13 or 15(d)]Source: Adhera Therapeutics, Inc. (0000737207) | Published: May 18, 2018 - 9:01 pmNT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBSource: Adhera Therapeutics, Inc. (0000737207) | Published: May 16, 2018 - 1:00 pm8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: May 3, 2018 - 9:00 pm10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]Source: Adhera Therapeutics, Inc. (0000737207) | Published: April 30, 2018 - 8:23 pmSC 13D/A [Amend] - General statement of acquisition of beneficial ownershipSource: Adhera Therapeutics, Inc. (0000737207) | Published: April 27, 2018 - 9:00 pmD - Notice of Exempt Offering of SecuritiesSource: Adhera Therapeutics, Inc. (0000737207) | Published: April 26, 2018 - 9:00 pm8-K - Current reportSource: Adhera Therapeutics, Inc. (0000737207) | Published: April 19, 2018 - 9:00 pm10-K - Annual report [Section 13 and 15(d), not S-K Item 405]Source: Adhera Therapeutics, Inc. (0000737207) | Published: April 17, 2018 - 9:32 pmNT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405Source: Adhera Therapeutics, Inc. (0000737207) | Published: April 3, 2018 - 1:00 pm View All Filings
